| Authors: |
Bivona TG; Department of Medicine, University of California, San Francisco, USA., Yanai I; NYU Langone Health, New York, USA., Calabrò F; Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Mechta-Grigoriou F; Stress and Cancer Laboratory, Institut Curie, Paris, France., Corleone G; Gene Expression and Cancer Model Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Di Martile M; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Tocci A; Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Tocci P; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Vaccarella S; Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Ferriero MC; Department of Urology, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Alimonti A; Department of Molecular Oncology, Institute of Oncology Research, Bellinzona, Switzerland., Ruppin E; Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, USA., Nisticò P; Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Bagnato A; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Blandino G; Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. giovanni.blandino@ifo.it.; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy. giovanni.blandino@ifo.it. |
